Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 8, 2013, Pages 1862-1871

  Bisio, Francesca ^a   Masini, Giulia ^a   Vacca, Elisabetta Blasi ^a   Calzi, Anna ^a   Cardinale, Francesco ^a   Bruzzone, Bianca ^a   Bruzzi, Paolo ^a   Viscoli, Claudio ^a   Kento Mwana, K ^a   Nkouendolo, Jean Pierre ^b   Moutou, Joseph ^c   Banguissa, Hubert ^d   Nicolini, Laura ^a   Schenone, Eva ^a   Repetto, Ernestina ^a   Montaldo, Chiara ^a   Ferrando, Sara ^a   Righi, Elda ^a   Dentone, Chiara ^a   Farinella, Sara Tita ^a   Vitale, Francesco ^a   Izzo, Manuela ^a   Mularoni, Alessandra ^a   Mikulska, Malgorzata ^a   Di Stefano, Letizia ^a   Malfatto, Emanuele ^a   Bernardini, Claudia ^a   Ginocchio, Francesca ^a   Secondo, Giovanni ^a   Delfino, Emanuele ^a   Nicco, Elena ^a   Prinapori, Roberta ^a   Parisini, Andrea ^a   De Hoffer, Laura ^a   Mesini, Alessio ^a   Grignolo, Sara ^a   Taramasso, Lucia ^a   Giacobbe, Daniele Roberto ^a   Artom, Francesco ^a   Dini, Simone ^a   Beltrame, Andrea ^a   Ratto, Sandra ^a   Mbongou, Franc Astyanax Mayinda ^e   Miguel, Landry Martial ^e   Nzagou, Abdon Claude ^e   Mayembo, Patrice ^e   Ibata, Daniel ^e   Ventura, Agostina ^a   Nigro, Nicola ^a   Andrei, Cristina ^a   Icardi, Giancarlo ^a   more..

^a UNIVERSITY OF GENOA   (Italy)

^b Departmental Unit Against AIDS   (Congo)

^c Departmental Direction of the Ministry of Health   (Congo)

^d Tié Tié Hospital   (Congo)

^e Army Hospital   (Congo)

Author keywords

Attrition; Drop out; Lost to follow up; Mother to child transmission; PMTCT

Indexed keywords

CHLORHEXIDINE; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NEVIRAPINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; CONGO; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEALTH PROGRAM; HEALTH PROMOTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALARIA; MALE; NEWBORN; PATIENT COMPLIANCE; PATIENT COUNSELING; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PRENATAL CARE; PROPHYLAXIS; TELEMEDICINE; TREATMENT DURATION; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT; VERTICAL TRANSMISSION;

ATTRITION; DROP-OUT; LOST TO FOLLOW-UP; MOTHER-TO-CHILD TRANSMISSION; PMTCT;

CONGO; FEMALE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 84880742314     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt102     Document Type: Article

References (34)

1. Siegfried N, van der Merwe L, Brocklehurst P et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2011; issue 7: CD003510.
2. Mofenson LM. Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection. Clin Infect Dis 2010; 50 Suppl 3: S130-48.
3. Chasela CS, Hudgens MG, Jamieson DJ et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010; 362: 2271-81.
4. Shapiro RL, Hughes MD, Ogwu A et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010; 362: 2282-94.
5. Tchendjou P, Same-Ekobo C, Nga A et al. Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon. PLoS One 2010; 5: e10411.
6. Bruzzone B, Bisio F, Ventura A et al. HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays. Trop Med Int Health 2008; 13: 900-3.
7. Bruzzone B, Ventura A, Bisio F et al. Impact of extensive HIV-1 variability on molecular diagnosis in the Congo basin. J Clin Virol 2010; 47: 372-5.
8. De Cock KM, Fowler MG, Mercier E et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000; 283: 1175-82.
9. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 506-10.
10. Kourtis AP, Lee FK, Abrams EJ et al. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006; 6: 726-32.
11. Kabamba Mulongo L, Schirvel C, Mukalay wa Mukalay A et al. HIV-1 test acceptance within the prevention of mother-to-child HIV-1 transmission program in Democratic Republic of Congo. Rev Epidemiol Sante Publique 2010; 58: 313-21.
12. Stringer JS, Sinkala M, Maclean CC et al. Effectiveness of a citywide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS 2005; 19: 1309-15.
13. Meda N, Leroy V, Viho I et al. Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa. AIDS 2002; 16: 2323-8.
14. Kurewa EN, Kandawasvika GQ, Mhlanga F et al. Realities and challenges of a five year follow up of mother and child pairs on a PMTCT program in Zimbabwe. Open AIDS J 2011; 5: 51-8.
15. Azcoaga-Lorenzo A, Ferreyra C, Alvarez A et al. Effectiveness of a PMTCT programme in rural Western Kenya. AIDS Care 2011; 23: 274-80.
16. Chilongozi D, Wang L, Brown L et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J 2008; 27: 808-14.
17. Kurewa NE, Munjoma MM, Chirenje ZM et al. Compliance and loss to follow up of HIV negative and positive mothers recruited from a PMTCT programme in Zimbabwe. Cent Afr J Med 2007; 53: 25-30.
18. Sherman GG, Jones SA, Coovadia AH et al. PMTCT from research to reality: results from a routine service. S Afr Med J 2004; 94: 289-92.
19. Manzi M, Zachariah R, Teck R et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health 2005; 10: 1242-50.
20. CNLS-Conseil National de Lutte contre le SIDA. Rapport évaluation nationale de la séroprévalence. http://www.cnls-congobrazza.org/downloads/ RAPPORTS_t4203.html (10 February 2013, date last accessed).
21. Kirsten I, Sewangi J, Kunz A et al. Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One 2011; 6: e21020.
22. Byakika-Tusiime J, Crane J, Oyugi JH et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav 2009; 13 Suppl 1: 82-91.
23. Karcher H, Omondi A, Odera J et al. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 2007; 12: 687-94.
24. Jones SA, Sherman GG, Varga CA. Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa. AIDS Care 2005; 17: 466-70.
25. Thomson KA, Cheti EO, Reid T. Implementation and outcomes of an active defaulter tracing system for HIV, prevention of mother to child transmission of HIV (PMTCT), and TB patients in Kibera, Nairobi, Kenya. Trans R Soc Trop Med Hyg 2011; 105: 320-6.
26. Rotheram-Borus MJ, Richter L, Van Rooyen H et al. Project Masihambisane: a cluster randomised controlled trial with peer mentors to improve outcomes for pregnant mothers living with HIV. Trials 2011; 12: 2.
27. Chi BH, Stringer JS. Mobile phones to improve HIV treatment adherence. Lancet 2010; 376: 1807-8.
28. Nassali M, Nakanjako D, Kyabayinze D et al. Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program. AIDS Care 2009; 21: 1124-31.
29. Moth IA, Ayayo AB, Kaseje DO. Assessment of utilisation of PMTCT services at Nyanza Provincial Hospital, Kenya. SAHARA J 2005; 2: 244-50.
30. Auvinen J, Suominen T, Välimäki M. Male participation and prevention of human immunodeficiency virus (HIV) mother-to-child transmission in Africa. Psychol Health Med 2010; 15: 288-313.
31. Medley AM, Kennedy CE, Lunyolo S et al. Disclosure outcomes, coping strategies, and life changes among women living with HIV in Uganda. Qual Health Res 2009; 19: 1744-54.
32. WHO-World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach (2010 version). http://whqlibdoc.who.int/ publications/2010/9789241599818_eng.pdf (10 February 2013, date last accessed).
33. Painter TM, Diaby KL, Matia DM et al. Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire. Int J STD AIDS 2005; 16: 237-42.
34. Painter TM, Diaby KL, Matia DM et al. Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. BMJ 2004; 329: 543-7.